Alan Sebulsky Buys 100,000 MeiraGTx Units, Signaling Long‑Term Confidence in Gene‑Therapy Growth
Alan Sebulsky’s first insider deal at MeiraGTx signals strong confidence in its gene‑therapy platform, highlighting potential for long‑term growth and favorable reimbursement.
4 minutes to read